SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-36927"
 

Search: onr:"swepub:oai:DiVA.org:umu-36927" > Tissue plasminogen ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Lindholm, ÅsaUppsala universitet,Institutionen för kvinnors och barns hälsa (author)

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome

  • Article/chapterEnglish2010

Publisher, publication year, extent ...

  • 2010-05-26
  • Informa UK Limited,2010
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-36927
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-36927URI
  • https://doi.org/10.3109/09513590.2010.487592DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-134161URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • OBJECTIVE: Disturbances in the fibrinolytic system are predictors of future cardiovascular events. The aim of this study was to compare plasminogen activator inhibitor 1 (PAI-1) activity and tissue plasminogen activator (tPA) mass concentration between patients with polycystic ovary syndrome (PCOS) and control subjects. DESIGN: One hundred thirty-five patients with PCOS (lean and obese) and 81 healthy controls were recruited for the study. Blood samples for PAI-1 activity and tPA mass were collected together with anthropometric measures. RESULTS: Obese patients with PCOS displayed increased tPA mass concentration in comparison with controls (p <0.05), and this finding was consistent regardless of whether patients displayed signs of hyperandrogenism or not. When hyperandrogenism was introduced as a prerequisite for the PCOS diagnosis, obese patients with PCOS displayed increased PAI-1 activity as well, p <0.05. Lean patients with PCOS did not differ in terms of PAI-1 activity or tPA mass concentration in comparison to controls. CONCLUSION: Obese women with PCOS have impaired fibrinolysis, in particular if they also display objective biochemical markers of hyperandrogenism.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Bixo, MarieUmeå universitet,Obstetrik och gynekologi(Swepub:umu)mabi0001 (author)
  • Eliasson, MatsUmeå universitet,Medicin(Swepub:umu)mael0021 (author)
  • Hudecova, MiriamUppsala universitet,Institutionen för kvinnors och barns hälsa(Swepub:uu)mirhu986 (author)
  • Arnadottir, RagnheidurUppsala universitet,Institutionen för kvinnors och barns hälsa(Swepub:uu)ragoa862 (author)
  • Holte, JanUppsala universitet,Institutionen för kvinnors och barns hälsa (author)
  • Sundström Poromaa, IngerUppsala universitet,Institutionen för kvinnors och barns hälsa(Swepub:uu)inspo702 (author)
  • Uppsala universitetInstitutionen för kvinnors och barns hälsa (creator_code:org_t)

Related titles

  • In:Gynecological Endocrinology: Informa UK Limited26:10, s. 743-7480951-35901473-0766

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view